WithdrawnNot Applicable

Intraoperative TAP Block After Repeat Cesarean

Stopped: No funding became available for this study to be feasible

0Started 2026-01-01

Plain-language summary

The aim of this study is to perform a randomized trial to investigate if intraoperative surgeon administered TAP block reduces pain and use of oral and parenteral pain medications after repeat cesarean delivery. The investigators aim to compare surgeon administered TAP block with liposomal bupivacaine compared to standard treatment (i.e. no TAP block) with regard to the primary outcome of post-operative narcotic use.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women presenting for elective repeat cesarean delivery at 37-42 weeks gestational age. * Pregnancy and delivery care obtained at UMass Memorial Medical Center * Patients able to provide written informed consent * English, Spanish, or Portuguese-speaking patients Exclusion Criteria: * Participants who are under the age of 18 years * Active labor. * Baseline pain score \> 6. * Unable to provide informed consent. * Prisoners will be excluded from this research. * Narcotic use in the 2 weeks prior to delivery. * Active substance abuse. * Inability to take narcotic analgesia.

What they're measuring

Daily Narcotic Use in Morphine Equivalents

Timeframe: From time of surgery through postpartum day 4

Trial details

NCT IDNCT05393908

SponsorUniversity of Massachusetts, Worcester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Post-operative Pain trials